Hjem › Kimcelle- og embryonalt cancer › Ohio
Kimcelle- og embryonalt cancer kliniske forsøg i Ohio
5 studier for Kimcelle- og embryonalt cancer søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 3
Alder 11 til 50 · Alle køn · Opdateret 1. sep. 2026 · NCT02582697Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Children's Hospital Medical Center of Akron, Akron
- OhioHealth O'Bleness Hospital, Athens
- Strecker Cancer Center-Belpre, Belpre
- og 38 flere
RekruttererFase 3
Alle aldre · Alle køn · Opdateret 25. aug. 2026 · NCT03067181Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- The Ohio State University, Columbus
RekruttererFase 1
Alder 15 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT06276491Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 1/2
Alder 4 til 39 · Alle køn · Opdateret 20. jul. 2026 · NCT05278208A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.